Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi Global Corporate Bond 1-5Y Highest Rated ESG UCITS ETF USD Hedged Acc

GCRE · LU2780870932 · class UCITS ETF USD Hedged Acc · USD · domicile Luxembourg
Bonds · Corporate USD · 1-5 years · GlobalUSD-hedged share classSFDR art. 8
Index tracked: Bloomberg MSCI ESG Global Corporate A+ 1-5 Year Select Index
TER
0.18%+ trans. 0.01%
Fund size
593 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Duration
2.49 yrsshort (≤3 years)
Launch 21 May 2024 · costs from the KID as of 2 Sept 2026 · 1,997 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of Bloomberg MSCI ESG Global Corporate A+ 1-5 Year Select Index (the "Index") and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of tracking error under normal market conditions is indicated in the Sub-Fund’s prospectus. The Index is a Total Return Index: the coupons paid by the index constituents are included in the index return. The Sub-Fund promotes environmental and/or…

Performance since series start (in euro) — base 100

21 May 20248 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2025202611199104
High 111 (3 Feb 2025) · low 99 (1 Jul 2025) · last 104. Past performance is not indicative of future results.

Returns in euro

1 year+2.9%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+4.2%

Risk · 1 / 3 / 5 years

Volatility (ann.)1.40%1.40%
Max drawdown−1.31%−1.31%
Sharpe-0.06-0.06
Sortino-0.09-0.09
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · GCRE · LU27808709321
RebalixGCRE · LU2780870932 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+5.93%+6.11%−0.18%

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.4%
Rating breakdown (% of fund)
AAA0.6%AA21.6%A77.1%Other0.6%
Maturity breakdown (% of fund)
Short term18.3%2 years53.3%5 years28.4%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 1,997 securities · top-10 weight = 2.3%
Countries (% of fund)
United States52.0%United Kingdom7.9%Canada7.2%France6.9%Germany6.0%
Sectors (% of fund)
Financials58.3%Health Care9.4%Consumer Discretionary9.2%Technology6.5%Industrials5.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
GCRE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 9 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU2780870932/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU2780870932/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU2780870932/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU2780870932
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · GCRE · LU27808709322